Intended for healthcare professionals

Letters Short term oral corticosteroid harms

Authors’ reply to Hamilton

BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2538 (Published 24 May 2017) Cite this as: BMJ 2017;357:j2538
  1. Akbar K Waljee, assistant professor,
  2. Mary A M Rogers, research associate professor,
  3. Brahmajee K Nallamothu, professor
  4. On behalf of all the authors
  1. University of Michigan Medical School, Ann Arbor, MI, USA
  1. awaljee{at}med.umich.edu

Hamilton highlights important points.12 If the concern is that the patient has an underlying condition such as asthma, the self controlled case series (SCCS) design incorporates a within person comparison. So, if the patient had asthma for five years, this is held constant and is controlled for in the analysis. However, if the patient developed asthma after having been given the corticosteroids, having concurrent asthma was not an “indication” for prescribing the drug. The SCCS design is very powerful in controlling for underlying comorbidities (and interactions among comorbidities) in a patient. In addition, the pattern of adverse events persisted across the various indications for treatment, showing consistency regardless of …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription